Acute myeloid leukemia and NK cells: two warriors confront each other

Acute myeloid leukemia and NK cells: two warriors confront each other

Acute myeloid leukemia (AML) is a heterogeneous disease whose therapies currently show elevated toxicity and a high rate of relapse. Recently, the burgeoning of new anti-tumor therapeutic strategies aimed at enhancing the immune response has pushed natural killer cells (NKs) into the spotlight. Thes...

Full description

Bibliographic Details
Main Authors: Aroa Baragaño Raneros, Carlos López-Larrea, Beatriz Suárez-Álvarez
Format: Article
Language:English
Published: Taylor & Francis Group 2019-02-01
Series:OncoImmunology
Subjects:
acute myeloid leukemia
natural killer cells
nkg2d
car-t
immunotherapy
immune checkpoints
Online Access:http://dx.doi.org/10.1080/2162402X.2018.1539617

Similar Items

Similar Items